Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Patent
1989-07-14
1991-01-15
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
A01N 3100, A61K 3110
Patent
active
049854658
ABSTRACT:
This invention relates to a method for inhibiting viral and retroviral infections via the use of various compounds, including antioxidants, and compounds corresponding to the formula ##STR1## wherein R in each occurrence thereof independently represents lower alkyl of from one to four carbon atoms, inclusive, and wherein R.sub.1 represents methyl and R.sub.2 represents methyl or ethyl. This invention further discloses methods for inhibiting viral and retroviral infections using compounds including bis(3,5-di-tert-butyl-4-hydroxyphenyl) acetone mercaptole, bis(3,5-di-tert-butyl-4-hydroxyphenyl) butanone mercaptole, bis(3-tert-butyl-4-hydroxy-5-isopropylphenyl) acetone mercaptole, bis(3-tert-butyl-4-hydroxy-5-methylphenyl) acetone mercaptole, 4,4'-thiobis(6-tert-butyl-o-cresol), 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl) benzene, 4,4'-methylenebis(2,6-di-tert-butylphenol), 2,6-di-tert-butyl-.alpha.-dimethylamino-p-cresol, and 4,4'-methylenebis(2,6-di-tert-butylphenol).
REFERENCES:
patent: 3574853 (1971-04-01), Barnhart
patent: 3576883 (1971-04-01), Neuworth
patent: 3692907 (1972-09-01), Fleming et al.
patent: 3862332 (1975-01-01), Barnhart et al.
patent: 4350707 (1982-09-01), Keith et al.
patent: 4560799 (1985-12-01), Spivack et al.
patent: 4719237 (1988-01-01), McCaughan
Snipes, Wallace, CA 82:149903x, 1975.
Carew, Thomas, CA 18016125d, 1988.
DeMeglio et al., Chem. Abst. 104:28675p (1986).
Mordasini et al., Chem. Abst. 96:7912x (1982).
Ramos et al., Chem. Abst. 95:150171g (1981).
Hoshide et al., Chem. Abst. 93:149970u (1980).
Hoshide et al., Chem. Abst. 93:94980q (1980).
Hoshide et al., Chem. Abst. 93:71280x (1980).
Prous et al., Chem. Abst. 89:16371v (1978).
Kabara et al., Chem. Abst. 88:83965j (1978).
Kritchevsky et al., Chem. Abst. 74:123504c (1971).
Barnhart et al., Chem. Abst. 73:64643b (1970).
Drake et al., Chem. Abst. 72:20544v (1970).
Hendler, S., "The Complete Guide to Anti-Aging Nutrients", Simon and Schuster, New York, (1984).
Cupp et al., Antimicrobial Agents and Chemotherapy 8:698-706 (1975).
Brugh, Science 197:1291-1292 (1977).
Oda, et al., Science 244:974-976 (1989).
Hendler, S., "The Oxygen Breakthrough", William Morrow and Company, Inc., New York (1989).
Nara, et al., Aids Res. and Human Retroviruses 3:283-302 (1987) (May Ann Liebert, publ.).
Nara and Fischinger, Nature 332:469-470 (1988).
Maeda, H., Science News, 325, May 27 (1989).
Pirtle, E. C., et al. Am. J. Vet. Res. 47:1892-1895 (1986).
Kim, K. S. et al., J. Infec. Dis. 138:91-94 (1978).
Keith, A. D. et al., Proc. Soc. Exp. Biol. and Med. 170:237-244 (1982).
Freeman, D. J., et al., Clin. Pharmacol. Ther. 38:56-59 (1985).
Wanda, P. et al., Antimicrobial Agents and Chemotherapy 10:96-101 (1976).
Hammersatedt, R. H. et al., Biology of Reproduction 14:381-397 (1976).
Carew, T. E. et al., PNAS U.S.A. 84:7725-7729 (1987).
Robinson Douglas W.
Travers R.
LandOfFree
Method for inhibiting viral and retroviral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting viral and retroviral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting viral and retroviral infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-55685